Daiichi Sankyo US · 21 hours ago
Associate Director, Regulatory Affairs CMC and Digital Transformation
Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies. The Associate Director, Regulatory Affairs CMC and Digital Transformation, is responsible for regulatory CMC activities and driving the organization's transition toward structured CMC data and digital capabilities.
Health CareTherapeuticsWellness
Responsibilities
Organize and manage the preparation (content and format) of all types of submissions to Health Authorities
Coordinates activities required for timely and accurate reporting of information to existing submissions
Supervise the identification and compilation of required documentation for submission
Prioritizes workload. Evaluate content and adequacy of submissions and identify deficiencies against regulatory guidance’s or internal data bases
Facilitate and support liaison activities with functional groups within Daiichi Sankyo, Inc. related to assigned products/project areas such as the clinical supplies organization, Reg Operations, Medical Affairs and labelling
Participates in meetings with Health Authorities
Prepares internal functional teams for these interactions to build strong relationships with FDA and secure successful meeting outcomes
Coordinates preparation, authors, and finalizes meeting materials to include meeting requests, briefing books and meeting minutes
Keep current with Regulatory guidelines and assists in educating the organization on evolving Regulatory Affairs CMC (RACMC) issues and regulations through internal technical seminars, global forums or trip reports
Participates on external industry consortiums (DS Consortium and Biophorum) to understand industry standards and contribute to policies and or standards. Identifies areas for process /procedure improvements and works on improvement implementation
Provides training on evolving regulations. This could involve Global RACMC teams or cross-functional initiatives within the company
Lead the transition to structured CMC data, including data standards, metadata models, and systems that support machine-readable regulatory submissions
Drive digital modernization by implementing tools for structured content authoring, automated data transfer, and data-driven dossier creation
Enable automation, AI, and analytics to reduce manual data handling, improve data integrity, and enhance decision-making across CMC functions
Partner cross-functionally with CMC, Quality, Manufacturing, Technical Operations, Regulatory, and IT to ensure alignment and readiness for structured data capabilities
Manage organizational change, including capability building, training, and communication to support adoption of new digital processes
Monitor global regulatory and industry trends and lead internal initiatives that position the company for future structured submission expectations and digital regulatory innovations
Qualification
Required
Bachelor's Degree Life Science Degree required
7 or More Years in the pharmaceutical industry with significant experience in scientific/regulatory fields required
Experience in Digital Transformation within Regulatory CMC required
Preferred
Master's Degree preferred
PharmD preferred
Experience in international Regulatory Affairs– CMC preferred
Experience with ICH M42(R2) and Ich M16 (SPQA) is preferred
Ability to travel up to 10% of the time
Company
Daiichi Sankyo US
Daiichi Sankyo US is a pharmaceutical company delivering innovative research, solutions, and treatments to improve health.
H1B Sponsorship
Daiichi Sankyo US has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (32)
2024 (25)
2023 (19)
2022 (12)
2021 (7)
2020 (6)
Funding
Current Stage
Late StageLeadership Team
Recent News
2025-06-01
2025-02-18
Company data provided by crunchbase